Drug Patents owned by Journey

1. Drug name - AMZEEQ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US10137200 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10086080 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10213512 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10517882 JOURNEY Method for healing of an infected acne lesion without scarring Oct, 2030

(7 years from now)

US10821187 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

US10849847 JOURNEY Compositions and methods for treating rosacea and acne Sep, 2037

(14 years from now)

US10398641 JOURNEY Compositions and methods for treating rosacea and acne Sep, 2037

(14 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Treatment of non-nodular acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 4% BASE AEROSOL, FOAM;TOPICAL Prescription

2. Drug name - QBREXZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US10548875 JOURNEY Glycopyrrolate salts
Feb, 2033

(10 years from now)

CN105026369A JOURNEY Glycopyrronium Salt
Sep, 2018

(4 years ago)

EP2961734A1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP3473615B1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP2961734B1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

EP3473615A1 JOURNEY Glycopyrrolate Salts
Feb, 2034

(11 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10052267 JOURNEY Topical glycopyrrolate formulations Oct, 2028

(6 years from now)

US8618160 JOURNEY Topical glycopyrrolate formulations Dec, 2029

(7 years from now)

US9744105 JOURNEY Topical glycopyrrolate formulations Jul, 2030

(7 years from now)

US10004717 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

US9259414 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

US10543192 JOURNEY Glycopyrrolate salts Feb, 2033

(10 years from now)

US8859610 JOURNEY Crystalline glycopyrrolate tosylate Feb, 2033

(10 years from now)

Drugs and Companies using GLYCOPYRRONIUM TOSYLATE ingredient

Treatment: Topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older

Dosage: CLOTH;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 2.4% BASE CLOTH;TOPICAL Prescription

3. Drug name - XIMINO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7919483 JOURNEY Method for the treatment of acne Mar, 2027

(4 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 67.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 90MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 112.5MG BASE CAPSULE, EXTENDED RELEASE;ORAL Discontinued
EQ 135MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription

4. Drug name - ZILXI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10213512 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8992896 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US9675700 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US8865139 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10322186 JOURNEY Topical tetracycline compositions Oct, 2030

(7 years from now)

US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses Oct, 2030

(7 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof Oct, 2030

(7 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

More Information on Dosage
Strength Dosage Availability
EQ 1.5% BASE AEROSOL, FOAM;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.